Back to Journals Drug Design, Development and Therapy Volume 19 Semaglutide Therapy and Accelerated Sarcopenia in Older Adults with Type 2 Diabetes: A 24-Month Retrospective Cohort Study Received 1 April 2025 Accepted for publication 25 June 2025 Published 3 July 2025 Volume 2025:19 Pages 56455652 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Tuo Deng Qingjuan Ren, Lei Zhi, Hongfang Liu Department of Geriatrics, Shijiazhuang Peoples Hospital, Shijiazhuang, Hebei, Peoples Republic of China Correspondence: Qingjuan Ren, Department of Geriatrics, Shijiazhuang Peoples Hospital, Shijiazhuang, Hebei, Peoples Republic of China, Email [email protected] Purpose: This study aimed to investigate changes in muscle mass and strength among older adults with type 2 diabetes who were treated with Semaglutide

He has worked as a clinical dietitian, founded and grown a large private practice, is author of The Tweaking Diet, and has developed MEALZEE, a meal-planning app used by health professionals across Australia and New Zealand
B.AveryC
At Winnett Specialist Group, we tailor the plan to your goals, health, and progress
Therefore, establishing a definitive causal relationship between semaglutide and dysgeusia in individual cases requires careful clinical evaluation and consideration of alternative explanations